I

Ikaros

59 employees

Ikaria develop and deliver innovative therapeutics and interventions to meet the significant needs of critically.

Basic info

pharmaceutical manufacturing

Biotechnology

Pulmonary Hypertension Secondary to COPD

Hepato-Renal Syndrome

Pulmonary Arterial Hypertension (PAH)

Therapeutics

Cardiac Remodeling post AMI (prevent CHF)

Medical

Hypoxic Respiratoty Failure

2007

$280M

from 8 investors over 8 rounds

I

Ikaros raised $280M on March 1, 2007

Investors: ARCH Venture Partners, Victory Schools, Inc. and New Mountain Capital, LLC, Venrock and Black Point Group

I

Ikaros raised $10M on April 27, 2005

Investors: ARCH Venture Partners, Venrock, Aravis and 5AM Ventures